Results for “Hashimoto’s thyroiditis”

Hypothyroidism

** Hypothyroidism is an endocrine disorder in which the thyroid gland fails to produce sufficient thyroid hormones, leading to a slowed metabolism and a wide range of systemic symptoms. **CONTENT:** ## Overview The thyroid gland, a butterfly‑shaped organ located at the base of the neck, synthesizes the hormones **thyroxine (T4)** and **triiodothyronine (T3)**. These hormones regulate basal metabolic rate, heart function, temperature control, and neurodevelopment. In **hypothyroidism**, the gland’s output falls below the body’s needs, causing a cascade of physiological changes. Common clinical manifestations include an intolerance to cold, profound fatigue, muscle aches, constipation, bradycardia (slow heart rate), depressive mood, and gradual weight gain despite unchanged dietary habits. A visible **goiter**—enlargement of the thyroid—may appear, especially when the underlying cause is iodine deficiency or autoimmune inflammation. The condition can be **primary** (originating within the thyroid itself) or **secondary** (resulting from pituitary or hypothalamic dysfunction). Primary hypothyroidism accounts for the vast majority of cases and is most often caused by **Hashimoto’s thyroiditis**, an autoimmune attack that gradually destroys thyroid tissue. Secondary hypothyroidism is rarer and typically follows pituitary surgery, radiation, or infiltrative disease. Regardless of etiology, untreated hypothyroidism can impair quality of life and, in severe cases, precipitate a **myxedema coma**, a medical emergency characterized by hypothermia, altered mental status, and respiratory failure. Pregnancy adds a critical dimension. Adequate maternal thyroid hormone is essential for fetal brain development, especially during the first trimester when the fetus relies entirely on maternal supply. Untreated maternal hypothyroidism increases the risk of **preterm birth, low birth weight, miscarriage**, and long‑term neurocognitive deficits in the child. Therefore, screening and timely treatment in pregnant women are standard of care. ## History/Background The clinical picture of an “underactive” thyroid was first described in the 19th century by physicians such as **Robert Graves** and **Thomas Addison**, who noted the association between goiter and sluggish metabolism. The term “hypothyroidism” entered medical literature in the early 1900s after the discovery of thyroid hormones by **Edward Calvin Kendall** and **Jack Gross**. In 1927, the first successful treatment using **synthetic thyroxine (levothyroxine)** was reported, revolutionizing management. The 1950s saw the development of the **radioimmunoassay**, enabling precise measurement of serum TSH (thyroid‑stimulating hormone) and facilitating early detection. More recently, the **American Thyroid Association (ATA)** published evidence‑based guidelines (2002, updated 2014 and 2021) that standardized screening, especially for high‑risk groups such as pregnant women and the elderly. ## Key Information - **Epidemiology:** Affects ~4–10 % of the U.S. population; prevalence rises with age and is higher in women (≈8 : 1 female‑to‑male ratio). - **Pathophysiology:** Primary hypothyroidism → reduced T4/T3 → loss of negative feedback → elevated TSH. Secondary hypothyroidism → insufficient TSH → low T4/T3 despite normal or low TSH. - **Diagnostic criteria:** Elevated serum TSH with low free T4 confirms primary disease; low/normal TSH with low free T4 suggests secondary disease. - **Treatment:** Daily oral **levothyroxine** (synthetic T4) titrated to normalize TSH; dosage adjustments are essential during pregnancy, weight change, or when interacting medications (e.g., calcium, iron, proton‑pump inhibitors) are introduced. - **Monitoring:** TSH is checked 6–8 weeks after dose changes; once stable, annual testing is typical. - **Complications:** Untreated disease → hyperlipidemia, atherosclerosis, myxedema coma; during pregnancy → fetal growth restriction, cretinism. - **When to seek care:** New or worsening fatigue, cold intolerance, unexplained weight gain, menstrual irregularities, or a visible neck swelling should prompt evaluation by a healthcare professional. Immediate medical attention is required for signs of myxedema coma (e.g., severe hypothermia, confusion, respiratory depression). ## Significance Hypothyroidism’s impact extends beyond individual health; it influences public health, economics, and societal productivity. Because symptoms are often subtle, many individuals remain undiagnosed, leading to unnecessary disability and healthcare costs. Universal screening in high‑risk populations (elderly, pregnant women, patients with autoimmune disease) has been shown to improve outcomes and reduce long‑term complications. Moreover, the disease exemplifies the success of hormone replacement therapy, a cornerstone of modern endocrinology. Ongoing research into **autoimmune mechanisms**, **genetic susceptibility**, and **novel delivery systems** (e.g., liquid levothyroxine, combination T4/T3 therapy) continues to refine management and personalize care. --- **INFOBOX:** - Name: Hypothyroidism - Type: Endocrine disorder (primary or secondary) - Date: First described in the 19th century; modern treatment established 1927 - Location: Global (affects individuals worldwide) - Known For: Insufficient production of thyroid hormones leading to metabolic slowdown **TAGS:** hypothyroidism, thyroid disease, endocrine disorders, levothyroxine, Hashimoto’s thyroiditis, pregnancy, autoimmune disease, metabolic health